Novel compound for targeted tumor therapy in patients with soft tissue sarcoma

Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001

04-Apr-2023 - Thermosome announced that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) and the responsible Ethics Committee to conduct a Phase 1 trial with its lead program THE001 in Germany. Patient enrollment is expected to start in Q2, 2023. The primary ...

Use of Artificial Intelligence in Drug Development

WACKER, CordenPharma, LMU and HU Berlin Train Machine Learning Algorithm for the Formulation of RNA Actives

03-Apr-2023 - Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched a project to accelerate the development of RNA-based drugs. The aim is to develop a new generation of lipid nanoparticles ...

Better infection diagnostics through spin-off at BNITM

(Ex-)employees found start-up "Panadea Diagnostics”

03-Apr-2023 - Scientists with entrepreneurial spirit: Researchers at the Bernhard Nocht Institute for Tropical Medicine (BNITM) have developed and patented a special technology for antibody detection, which will be marketed from April by a company founded specifically for this purpose. The board of the BNITM ...

Two young researchers on their way to becoming entrepreneurs

Start-ups for environmentally friendly batteries and nanoparticles for cancer therapy in planning

27-Mar-2023 - Two young Empa scientists each receive an Empa Entrepreneur Fellowship to develop innovative products based on their research. Abdessalem Aribia is developing environmentally friendly and safe batteries, while Subas Scheibler is working on nanoparticles for cancer therapy. The Empa Entrepreneur ...

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform

A revolution in drug discovery thanks to a new chat assistant?

16-Mar-2023 - Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, “ChatPandaGPT,” enables researchers to have ...

Chromologics raises additional funding, bringing the series seed to a total of EUR 12.6 M

15-Mar-2023 - Chromologics, the Danish biotech company specializing in production of innovative natural food colors, today announced the successful closure of an extended seed round. The company raised an additional EUR 7.1 million in equity from its existing investors plus two new investors. "We are thrilled ...

"Dr Jekyll and Mr Hyde" technique to fight cancer

Viennese start-up develops novel, precise anti-cancer drugs

06-Mar-2023 - RIANA Therapeutics, a promising pharmaceutical start-up recently spun out of the University of Veterinary Medicine Vienna (Vetmeduni), aims to develop novel therapeutics for cancer patients based in part on scientific findings from Vetmeduni’s Moriggl research group (Moriggl Lab). The ...

New spray fights infections and antibiotic resistance

The research on the antibacterial materials is being conducted in collaboration with the spin-off company Amferia

31-Jan-2023 - The World Health Organization (WHO) ranks antibiotic resistance as one of the top ten threats to global health. There is therefore a great need for new solutions to tackle resistant bacteria and reduce the use of antibiotics. A group of researchers at Chalmers University of Technology in Sweden ...

Voice data as a biomarker for disease

audEERING launches online platform for AI-based analysis of disease symptoms based on voice

31-Jan-2023 - The voice AI company audEERING has developed AI SoundLab, a DSGVO-compliant online platform that for the first time enables the determination of health conditions based on parameters of the human voice. Companies and institutions are thus able to explore voice data as biomarkers for disease ...

New high-tech startup developing smart contact lenses for glaucoma diagnosis and management

18-Jan-2023 - Optometrists, ophthalmologists and their patients will benefit from new, high-tech tools to detect glaucoma at its earliest stages thanks to a startup that will commercialize smart contact lenses developed at Purdue University. BVS Sight Inc. is the first company created through a partnership ...